LILLY FDA Approval ANDA 062592

ANDA 062592

LILLY

FDA Drug Application

Application #062592

Application Sponsors

ANDA 062592LILLY

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INTRAVENOUSEQ 750MG BASE/VIAL0KEFUROXCEFUROXIME SODIUM
002INJECTABLE;INJECTIONEQ 1.5GM BASE/VIAL0KEFUROXCEFUROXIME SODIUM

FDA Submissions

ORIG1AP1986-01-10
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1992-06-12
LABELING; LabelingSUPPL9AP1992-06-12
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1992-10-30
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1997-01-23
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1997-01-13
LABELING; LabelingSUPPL14AP1997-01-23
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1996-08-15
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2001-01-22
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2001-01-22
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2001-01-22
LABELING; LabelingSUPPL20AP2001-01-22
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2001-09-05
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2002-06-24
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2002-09-04
LABELING; LabelingSUPPL24AP2002-11-12
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2002-09-30
LABELING; LabelingSUPPL26AP2002-11-12

Submissions Property Types

SUPPL1Null0
SUPPL5Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL15Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null1
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL25Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62592
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.